Marc Schegerin Morphic Holding, Inc. (MORF) insider trading activity

Marc Schegerin is CFO and COO of Morphic Holding, Inc.. Currently has a direct ownership of 0 shares of MORF, which is worth approximately $0. The most recent transaction as insider was on Aug 16, 2024, when has been sold 37,907 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

MARC SCHEGERIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 16 2024	SELL Sale (or disposition) back to the issuer	-	37,907 Reduced 100.0%	0 Common Stock
Jul 08 2024	SELL Open market or private sale	$2,451,628 $55.8 p/Share	43,936 Reduced 53.68%	37,907 Common Stock
Jul 08 2024	BUY Exercise of conversion of derivative security	$659,040 $15.0 p/Share	43,936 Added 34.93%	81,843 Common Stock
Jan 16 2024	SELL Open market or private sale	$166,067 $27.49 p/Share	6,041 Reduced 13.89%	37,460 Common Stock
Jan 14 2024	BUY Exercise of conversion of derivative security	-	4,690 Added 9.73%	43,501 Common Stock
Jan 13 2024	BUY Exercise of conversion of derivative security	-	14,675 Added 27.44%	38,811 Common Stock
Sep 07 2023	SELL Open market or private sale	$1,081,200 $54.06 p/Share	20,000 Reduced 45.31%	24,136 Common Stock
Sep 07 2023	BUY Exercise of conversion of derivative security	$300,000 $15.0 p/Share	20,000 Added 31.18%	44,136 Common Stock
Apr 25 2023	SELL Open market or private sale	$2,735,500 $54.71 p/Share	50,000 Reduced 67.44%	24,136 Common Stock
Apr 25 2023	BUY Exercise of conversion of derivative security	$750,000 $15.0 p/Share	50,000 Added 40.28%	74,136 Common Stock
Mar 09 2023	BUY Exercise of conversion of derivative security	$99,990 $15.0 p/Share	6,666 Added 21.92%	23,740 Common Stock
Mar 07 2023	SELL Open market or private sale	$2,250,000 $45.0 p/Share	50,000 Reduced 74.54%	17,074 Common Stock
Mar 07 2023	BUY Exercise of conversion of derivative security	$750,000 $15.0 p/Share	50,000 Added 42.71%	67,074 Common Stock
Jan 14 2023	SELL Open market or private sale	$51,152 $30.63 p/Share	1,670 Reduced 9.34%	16,212 Common Stock
Jan 14 2023	BUY Exercise of conversion of derivative security	-	4,690 Added 20.78%	17,882 Common Stock
Nov 02 2021	SELL Exercise of conversion of derivative security	$99,990 $15.0 p/Share	6,666 Reduced 33.57%	13,192 Common Stock
Nov 01 2021	SELL Open market or private sale	$328,620 $60.0 p/Share	5,477 Reduced 45.63%	6,526 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$82,155 $15.0 p/Share	5,477 Added 31.33%	12,003 Common Stock
Oct 26 2021	SELL Open market or private sale	$2,220 $60.0 p/Share	37 Reduced 0.56%	6,526 Common Stock
Oct 26 2021	BUY Exercise of conversion of derivative security	$555 $15.0 p/Share	37 Added 0.56%	6,563 Common Stock
Oct 15 2021	SELL Open market or private sale	$200,280 $60.0 p/Share	3,338 Reduced 33.84%	6,526 Common Stock
Oct 15 2021	BUY Exercise of conversion of derivative security	$50,070 $15.0 p/Share	3,338 Added 25.28%	9,864 Common Stock
Oct 14 2021	SELL Open market or private sale	$1,451,524 $60.02 p/Share	24,184 Reduced 78.75%	6,526 Common Stock
Oct 14 2021	BUY Exercise of conversion of derivative security	$362,760 $15.0 p/Share	24,184 Added 44.06%	30,710 Common Stock
Oct 13 2021	SELL Open market or private sale	$117,840 $60.0 p/Share	1,964 Reduced 23.13%	6,526 Common Stock

Also insider at

SQZ

SQZ Biotechnologies Co Healthcare

Director

Marc Schegerin

CFO and COO

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MORF shares.

Notify only if

Value

Insider Trading

Get notified when an Morphic Holding, Inc. insider buys or sells MORF shares.

Notify only if

Operation

Value

Type

News

Receive news related to Morphic Holding, Inc.

Track Activities on MORF

Account